Videos de Experimentos Relacionados
La psoriasis en la práctica
1Department of Dermatology, Baylor University Medical Center, Dallas, Texas 75246.
Lancet (London, England)
|July 27, 1991
Resumen
No abstract available in PubMed .
Videos de Conceptos Relacionados
También podría leer
Artículos Relacionados
Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.
Ordenar por
Same author
Effect of baseline disease severity on achievement of treatment target with apremilast: results from a pooled analysis.
Journal of the European Academy of Dermatology and Venereology : JEADV·2021
Same author
Describing the burden of the COVID-19 pandemic in people with psoriasis: findings from a global cross-sectional study.
Journal of the European Academy of Dermatology and Venereology : JEADV·2021
Same author
Defining trajectories of response in patients with psoriasis treated with biologic therapies.
The British journal of dermatology·2021
Same author
Risk-mitigating behaviours in people with inflammatory skin and joint disease during the COVID-19 pandemic differ by treatment type: a cross-sectional patient survey.
The British journal of dermatology·2020
Same author
Efficacy of risankizumab in patients with moderate-to-severe plaque psoriasis by baseline demographics, disease characteristics and prior biologic therapy: an integrated analysis of the phase III UltIMMa-1 and UltIMMa-2 studies.
Journal of the European Academy of Dermatology and Venereology : JEADV·2020
Same author
Long-term efficacy and safety of brodalumab in psoriasis through 120 weeks and after withdrawal and retreatment: subgroup analysis of a randomized phase III trial (AMAGINE-1).
The British journal of dermatology·2020
Same journal
Assisted dying and the silencing of medicine's next generation.
Lancet (London, England)·2026
Same journal
Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.
Lancet (London, England)·2026
Same journal
Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.
Lancet (London, England)·2026
Same journal
[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.
Lancet (London, England)·2026
Same journal
Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.
Lancet (London, England)·2026